• Steven A Cowman, Joseph Jacob, David M Hansell, Peter Kelleher, Robert Wilson, Cookson William O C WOC 1 National Heart and Lung Institute, Imperial College London, London, United Kingdom., Miriam F Moffatt, and Michael R Loebinger.
• 1 National Heart and Lung Institute, Imperial College London, London, United Kingdom.
• Am. J. Respir. Cell Mol. Biol. 2018 Apr 1; 58 (4): 510-518.

AbstractThe factors predisposing toward the development of pulmonary nontuberculous mycobacterial (pNTM) disease and influencing disease progression remain unclear. Impaired immune responses have been reported in individuals with pNTM disease, but data are limited and inconsistent. In this study, we sought to use gene expression profiling to examine the host response to pNTM disease. Microarray analysis of whole-blood gene expression was performed on 25 subjects with pNTM disease and 27 uninfected control subjects with respiratory disease. Gene expression results were compared with phenotypic variables and survival data. Compared with uninfected control subjects, pNTM disease was associated with downregulation of 213 transcripts enriched for terms related to T cell signaling, including IFNG. Reduced IFNG expression was associated with more severe computed tomography changes and impaired lung function. Mortality was associated with the expression of transcripts related to the innate immune response and inflammation, whereas transcripts related to T and B cell function were associated with improved survival. These findings suggest that pNTM disease is associated with an aberrant immune response, which may reflect an underlying propensity to infection or result from NTM infection itself. There were important differences in the immune response associated with survival and mortality in pNTM disease.

31 keywords...

hide…